Table 4.
Correlations between MRI (DTI-metrics) and immunological parameters.
| Variable | With variable | RSp (95% C.L.) | P value |
|---|---|---|---|
| aMCI | |||
| FA_CC2 | CD14+/PD-L1+ | 0.53 (0.01; 0.82) | 0.0389 |
| FA_CC3 | CD14+/PD-L1+ | 0.66 (0.21; 0.87) | 0.0057 |
| FA_CC2 | CD4+/BDNF+ | 0.64 (0.08; 0.88) | 0.0226 |
| FA_CC3 | CD4+/BDNF+ | 0.62 (0.05; 0.88) | 0.0284 |
| FA_CC2 | CD8+/BDNF+ | 0.69 (0.16; 0.90) | 0.0116 |
| FA_CC3 | CD8+/BDNF+ | 0.81 (0.40; 0.94) | 0.0008 |
| AD | |||
| FA_CC3 | CD4+/IL-21+ | −0.41 (−0.68; −0.02) | 0.0346 |
AD, Alzheimer’s disease; aMCI, amnestic mild cognitive impairment; CC, corpus callosum; FA, fractional anisotropy; RSp, Spearman correlation coefficient and 95% confidence limits performed by Fisher’s Z transformation.